BloombergSen Inc. Acquires Shares of 75,708 UnitedHealth Group Incorporated $UNH

BloombergSen Inc. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 75,708 shares of the healthcare conglomerate’s stock, valued at approximately $23,619,000. UnitedHealth Group accounts for 1.4% of BloombergSen Inc.’s portfolio, making the stock its 15th biggest position.

Other hedge funds have also recently modified their holdings of the company. Citizens National Bank Trust Department lifted its position in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its position in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares during the period. Caitlin John LLC raised its stake in shares of UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $1,324,000. Finally, Wealth Effects LLC raised its stake in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after acquiring an additional 591 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on UNH. JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research note on Wednesday, August 6th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Stock Up 0.7%

NYSE:UNH opened at $347.82 on Thursday. The firm has a market capitalization of $315.01 billion, a P/E ratio of 15.07, a PEG ratio of 2.25 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company’s fifty day moving average price is $304.76 and its 200-day moving average price is $357.57. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.